Is reduction of Plasma MicroRNA-21 Associated with Chemotherapeutic Response in Patients with Non-small Cell Lung Cancer?
Plasma miR-21 is a good biomarker for NSCLC, and could be used to predict responses to chemotherapy.
We conclude that AD induces characteristics consistent with cellular senescence in androgen-sensitive prostate cancer cells. This finding may explain incomplete tumor regression in response to AD.